Cormorant Asset Management’s Ventyx Biosciences VTYX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,710,000
| Closed | -$14.9M | – | 64 |
|
|
2024
Q1 | $14.9M | Buy |
+2,710,000
| New | +$14.9M | 0.65% | 38 |
|
|
2023
Q1 | – | Sell |
-1,080,643
| Closed | -$35.4M | – | 81 |
|
|
2022
Q4 | $35.4M | Buy |
1,080,643
+299,997
| +38% | +$9.84M | 2.37% | 11 |
|
|
2022
Q3 | $27.3M | Buy |
780,646
+3
| +0% | +$105 | 1.9% | 19 |
|
|
2022
Q2 | $9.55M | Sell |
780,643
-4,660
| -0.6% | -$57K | 0.72% | 41 |
|
|
2022
Q1 | $10.7M | Hold |
785,303
| – | – | 0.82% | 37 |
|
|
2021
Q4 | $15.1M | Buy |
+785,303
| New | +$15.1M | 0.9% | 30 |
|